Daprodustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor used in the treatment of anemia associated with chronic kidney disease. This category provides essential materials for the analytical… Read more





Daprodustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor used in the treatment of anemia associated with chronic kidney disease. This category provides essential materials for the analytical testing and quality control of this small-molecule medication. Laboratories use our range of high-quality reference standards, including the active pharmaceutical ingredient, to ensure accurate quantification and drug potency assessment. Researchers also rely on our comprehensive selection of impurities—such as dicyclohexylurea derivatives and processing-related compounds—for rigorous impurity profiling and method validation. Additionally, the inclusion of metabolites and stable isotope-labelled compounds supports complex bioanalytical studies, allowing for precise mass spectrometry-based detection and pharmacokinetic analysis. These products are critical for maintaining regulatory compliance and ensuring consistency throughout the pharmaceutical development and manufacturing process.